<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161485">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01961895</url>
  </required_header>
  <id_info>
    <org_study_id>Altermatt 09-148</org_study_id>
    <nct_id>NCT01961895</nct_id>
  </id_info>
  <brief_title>Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture</brief_title>
  <official_title>Evaluation of the Effect of Perioperative Continuous Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <authority>Chile: Institutional Review Board</authority>
    <authority>Chile: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is evaluate the efficacy of perioperative continuous lumbar plexus
      block in reducing the risk of cardiac ischemic events of elderly patients undergoing surgery
      for hip fractures, expressed as a reduction of ischemic events per subject.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>evaluate the efficacy of perioperative continuous lumbar plexus block in reducing the risk of cardiac ischemic events of elderly patients undergoing surgery for hip fractures, expressed as a reduction of ischemic events per subject.</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major cardiovascular events (myocardial infarction, acute pulmonary edema, arrhythmias).</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital death</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death at 30, 90 and 360 days after surgery</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative Pain Intensity, measured in numerical rating scale (NRS).</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Adverse events (hypotension, respiratory depression, systemic toxicity, etc..)</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Hip Fractures</condition>
  <condition>Perioperative Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Intravenous patient-controlled analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous morphine solution 0.2 mg / ml in PCA mode without basal infusion, 1mg bolus demand and lockout of 8 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous lumbar plexus (LP) block analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous lumbar plexus (LP) block analgesia. Continuous infusion of a solution of 0.1% bupivacaine in PCA mode, programmed at 8 ml / h.
Rescue bolus 5 ml and 30 minutes lockout</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous lumbar plexus (LP) block analgesia</intervention_name>
    <arm_group_label>Continuous lumbar plexus (LP) block analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous patient-controlled analgesia</intervention_name>
    <arm_group_label>Intravenous patient-controlled analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with hip fracture within 48 hours of evolution

          -  Known coronary artery disease:

        Previous myocardial infarction Chronic stable angina Atypical angina with positive
        exercise test for coronary flow failure. Evidence of coronary artery disease with
        ultrasound, scintigraphic or         angiographic compatible

          -  Patients with at least two of the risk factors for coronary heart disease as defined
             by Wallace (1998)

        Exclusion Criteria:

          -  Patients receiving orthopedic treatment.

          -  Patients with coagulopathy, clinic or laboratory.

          -  Patients with sepsis or infection of the catheter insertion site of lumbar plexus.

          -  Patients with neurological diseases evolving.

          -  Patients disoriented, or dementia.

          -  CKD stage IV National Kidney Foundation (2)

          -  Glomerular filtration rate between 15 and 29 mL/min/1, 73 m2

          -  Patients unable to use the Numeric Rating Scale (NRS) to assess pain.

          -  Patients with non-sinus rhythm or conduction abnormalities (right bundle   branch
             block or left, atrioventricular block) in the admission ECG

          -  Patients with pacemaker.

          -  Enrolled patients with acute coronary syndrome or decompensated cardiovascular
             disease at entry.

          -  Allergy to any of the drugs of the protocol.

          -  Inability to understand or unaided sign informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Division de Anestesia - Pontificia Universidad Catolica de Chile</name>
      <address>
        <city>Santiago</city>
        <state>Region Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>División de Anestesia - Facultad de Medicina Pontificia Universidad Católica</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 11, 2013</lastchanged_date>
  <firstreceived_date>October 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Continuous lumbar plexus (LP) block analgesia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
